If you need more lookups,
subscriptions start at $34 USD/month.
Kevin Marks Location
Cambridge, MA, US
Kevin Marks Work
President and CEO @ (January 2024 - Present)
co-founder and President @ (July 2022 - January 2024)
Advisor @ (January 2024 - Present)
Entrepreneur in Residence @ (April 2022 - January 2024)
Head, Oncology Drug Discovery, Cambridge @ (September 2020 - March 2022)
Vice President of Biology @ (May 2018 - September 2020)
Sr. Director and Head of Cancer Biology @ (September 2016 - April 2018)
Director, Biology @ (May 2014 - August 2016)
Associate Director, Cell Metabolism @ (April 2011 - April 2014)
Senior Scientist, Cell Metabolism @ (February 2009 - March 2011)
Sr. Scientist @ (January 2006 - December 2009)
Scientist @ (January 2004 - December 2006)
Kevin Marks Education
Stanford University
PhD (Molecular Pharmacology/Chemical & Systems Biology)
1998-2003
Cornell University
BA (Biology)
1995-1998
Kevin Marks Skills
Biochemistry
Microsoft Excel
Biotechnology
Cell Culture
Molecular Biology
Musikbranche
B2G
Kevin Marks Summary
Kevin Marks, based in Cambridge, MA, US, is currently a President and CEO at Delphia Therapeutics. Kevin Marks brings experience from previous roles at Delphia Therapeutics, GV and Novartis Institutes for BioMedical Research (NIBR). Kevin Marks holds a 1998 - 2003 PhD in Molecular Pharmacology/Chemical & Systems Biology @ Stanford University. With a robust skill set that includes Biochemistry, Microsoft Excel, Biotechnology, Cell Culture, Molecular Biology and more. Kevin Marks has 7 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Kevin Marks?
Find contact details for 700 million professionals.